Viewpoint. Albumin and hypovolaemia: is the Cochrane evidence to be trusted?

Detalles Bibliográficos
Publicado en:Lancet Vol. 359; no. 9300; pp. 70 - 73
Autor principal: Horsey P
Formato: tables/charts Journal Article
Publicado: Lancet 1/5/2002
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106933069&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106933069
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01406736
        LAN
      jtl: Lancet
      issn: 01406736
      maglogo: N
    pubinfo:
      dt: 1/5/2002
      vid: 359
      iid: 9300
      pid: 1297
      pub: Lancet
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        106933069
        106933069
        2002064859
        10.1016/s0140-6736(02)07285-9
        NLM11809206
        106933069
      ppf: 70
      ppct: 3
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Viewpoint. Albumin and hypovolaemia: is the Cochrane evidence to be trusted?
      aug:
        au: Horsey P
      sug:
        subj:
          Albumins Adverse Effects
          Albumins Therapeutic Use
          Critically Ill Patients
          Systematic Review Methods
          Blood Volume
          Clinical Trials
          Cochrane Library
          Fluid Therapy
          Mortality
          Shock, Hemorrhagic Prevention and Control
      pubtype: Academic Journal
      doctype:
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N